<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="are almost 20 times more likely to die from their" exact="infection" post="than patients with lower D-dimer values.25 In contrast, most"/>
 <result pre="have evidence of systemic DIC.36â€&quot;39 Patients with ARDS from H1N1" exact="infection" post="had a greater than 20-fold increase in risk of"/>
 <result pre="in patients with other viral infections.48,49 Pathologic findings in SARS-CoV-2" exact="infection" post="Although there are only a few published pathologic reports"/>
 <result pre="small vessel occlusion.50,51 There are several mechanisms by which SARS-CoV-2" exact="infection" post="may result in microvascular and macrovascular thrombosis, including cytokine"/>
 <result pre="active area of investigation whether these are specific to SARS-CoV-2" exact="infection" post="or a final common pathway in the thromboinflammatory response"/>
 <result pre="(COVID-19). Multiple processes may contribute to COVID-19-associated coagulopathy including direct" exact="infection" post="of type II pneumocytes and endothelial cells, leading to"/>
 <result pre="that elevated plasminogen may be a risk factor for SARS-CoV-2" exact="infection" post="because plasmin may cleave the S protein of the"/>
 <result pre="its infectivity.94 These findings highlight the delicate balance between corralling" exact="infection" post="and uncontrolled inflammation and thrombosis. Therapeutic considerations Markers of"/>
 <result pre="trials will help define the role of heparin in the" exact="treatment" post="of hospitalized patients with COVID-19. Outside of a trial"/>
 <result pre="late physiologic anti-viral responses. The heterogenous response to the SARS-CoV-2" exact="infection" post="and the various time-dependent pathways driving pathology make universal"/>
 <result pre="temporal and mechanistic role each pathway plays in severe SARS-CoV-2" exact="infection" post="remains uncertain and requires further exploration for treatment opportunities"/>
 <result pre="severe SARS-CoV-2 infection remains uncertain and requires further exploration for" exact="treatment" post="opportunities as efforts to control this pandemic continue. Conclusions"/>
 <result pre="17 Mar 2020. DOI: 10.1002/jmv.25770. 4WanSXiangYFangW, et al.Clinical features and" exact="treatment" post="of COVID-19 patients in northeast Chongqing. J Med Virol."/>
 <result pre="al.D-dimer is a significant prognostic factor in patients with suspected" exact="infection" post="and sepsis. Am J Emerg Med2012; 30: 1991â€&quot;1999.22795996 31WanJYangXHeW,"/>
 <result pre="Prevention. Intensive-care patients with severe novel influenza A (H1N1) virus" exact="infection" post="â€&quot; Michigan, June 2009. MMWR Morb Mortal Wkly Rep2009;"/>
 <result pre="J Intern Med2015; 26: 596â€&quot;598.26365372 38BuncePEHighSMNadjafiM, et al.Pandemic H1N1 influenza" exact="infection" post="and vascular thrombosis. Clin Infect Dis2011; 52: e14â€&quot;17.21288835 39ObiATTignanelliCJJacobsBN,"/>
 <result pre="of print 30 April 2020. DOI: 10.1002/ccd.28948. 47Corrales-MedinaVFMadjidMMusherDM.Role of acute" exact="infection" post="in triggering acute coronary syndromes. Lancet Infect Dis2010; 10:"/>
 <result pre="of SARS. J Pathol2006; 210: 288â€&quot;297.17031779 91VargaZFlammerAJSteigerP, et al.Endothelial cell" exact="infection" post="and endotheliitis in COVID-19. Lancet2020; 395: 1417â€&quot;1418.32325026 92GralinskiLEBankheadA3rdJengS, et"/>
 <result pre="Rev2020; 100: 1065â€&quot;1075.32216698 95JaimesFDe La RosaGMoralesC, et al.Unfractioned heparin for" exact="treatment" post="of sepsis: A randomized clinical trial (The HETRASE Study)."/>
 <result pre="trial of monoclonal antibody to human tumour necrosis factor in" exact="treatment" post="of septic shock. NORASEPT II Study Group. Lancet1998; 351:"/>
 <result pre="syndrome. N Engl J Med2006; 354: 1671â€&quot;1684.16625008 101TangNBaiHChenX, et al.Anticoagulant" exact="treatment" post="is associated with decreased mortality in severe coronavirus disease"/>
 <result pre="N Engl J Med1994; 330: 377â€&quot;381.8284001 108ParanjpeIFusterVLalaA, et al.Association of" exact="treatment" post="dose anticoagulation with in-hospital survival among hospitalized patients with"/>
 <result pre="chronic inflammation. J Infect Dis2020; 221: 1598â€&quot;1606.31282542 111LiZLiXHuangY-Y, et al.FEP-based" exact="screening" post="prompts drug repositioning against COVID-19. bioRxiv. Preprint 25 March"/>
</results>
